Patents by Inventor Julien DEFAUX

Julien DEFAUX has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8461178
    Abstract: The present invention relates to kinase modulators of the naphthyridine type and to the preparation and use thereof as medicaments for the modulation of misdirected cellular signal transduction processes, in particular for influencing the function of tyrosine and serine/threonine kinases and for the treatment of malignant or benign tumors and other disorders based on pathological cell proliferation, such as, for example, restenosis, psoriasis, arteriosclerosis and cirrhosis of the liver.
    Type: Grant
    Filed: November 24, 2010
    Date of Patent: June 11, 2013
    Assignee: Aeterna Zentaris GmbH
    Inventors: Tilmann Schuster, Matthias Gerlach, Irene Seipelt, Emmanuel Polymeropoulos, Gilbert Mueller, Eckhard Guenther, Pascal Marchand, Julien Defaux
  • Publication number: 20110150831
    Abstract: The present invention relates to kinase modulators of the naphthyridine type and to the preparation and use thereof as medicaments for the modulation of misdirected cellular signal transduction processes, in particular for influencing the function of tyrosine and serine/threonine kinases and for the treatment of malignant or benign tumours and other disorders based on pathological cell proliferation, such as, for example, restenosis, psoriasis, arteriosclerosis and cirrhosis of the liver.
    Type: Application
    Filed: November 24, 2010
    Publication date: June 23, 2011
    Applicant: AETERNA ZENTARIS GmbH
    Inventors: Tilmann SCHUSTER, Matthias GERLACH, Irene SEIPELT, Emmanuel POLYMEROPOULOS, Gilbert MUELLER, Eckhard GUENTHER, Pascal MARCHAND, Julien DEFAUX